Zydus Pharmaceuticals (USA) Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Zydus Pharmaceuticals (USA) Inc.
Former sales and marketing exec at Taro Pharmaceuticals is latest exec charged with participating in price fixing conspiracies.
Following the expiry of Perrigo’s 180-day exclusivity for its generic version of AndroGel, firms including Lupin and Teva have launched their own generic testosterone 1.62% gels in the US.
Cipla, which previously settled with Amgen, alleges Sensipar's formulation patent is currently unenforceable due to ‘patent misuse,’ and brand sponsor’s deal with Teva following a brief generic launch violates federal antitrust law and California state law.
Dr Reddy’s has had a record number of US launches in Q3 with potentially more in store and now a new US CEO to steer things through, improving outlook for a significant revival in earnings. But risks of delays and competition in certain key anticipated launches in 2019 could dull prospects.
- Generic Drugs
- OTC, Consumer
Drug Discovery Tools
- Natural Products
- Molecular Diversity
- Drug Discovery Tools